Revenue is expected to grow at a compound annual rate of 2.9% to €28.8 billion over the five years through 2023, including forecast growth of 4.5% in 2023. Pharmaceutical wholesalers' revenue has benefitted from demographical trends including Ireland's ageing population and the rising prevalence of chronic conditions (e. g. diabetes, obesity and associated health complications). New products and legislation to promote high-tech pharmaceuticals have also supported industry expansion. This industry includes companies that wholesale pharmaceuticals and medical goods, including prescription medicines and equipment such as pacemakers and CT scanners. These are distributed to pharmacies, specialist retailers, hospitals, doctors and specialist medical practitioners. This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.Booster shot: Rising use of high-tech pharmaceuticals has pushed up revenue
Table of Contents
ABOUT THIS INDUSTRY- Industry Definition
- Main Activities
- Similar Industries
- Additional Resources
INDUSTRY PERFORMANCE
- Executive Summary
- Key External Drivers
- Current Performance
- Industry Outlook
- Industry Life Cycle
- Supply Chain
- Products & Services
- Demand Determinants
- Major Markets
- International Trade
- Business Locations
- Market Share Concentration
- Key Success Factors
- Cost Structure Benchmarks
- Basis of Competition
- Barriers to Entry
- Industry Globalization
OPERATING CONDITIONS
- Capital Intensity
- Technology & Systems
- Revenue Volatility
- Regulation & Policy
- Industry Assistance
- Industry Data
- Annual Change
- Key Ratios
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- United Drug (Wholesale) Ltd
Methodology
LOADING...